154 related articles for article (PubMed ID: 35676421)
1. Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.
MotieGhader H; Tabrizi-Nezhadi P; Deldar Abad Paskeh M; Baradaran B; Mokhtarzadeh A; Hashemi M; Lanjanian H; Jazayeri SM; Maleki M; Khodadadi E; Nematzadeh S; Kiani F; Maghsoudloo M; Masoudi-Nejad A
Sci Rep; 2022 Jun; 12(1):9417. PubMed ID: 35676421
[TBL] [Abstract][Full Text] [Related]
2. Network-based identification of key proteins and repositioning of drugs for non-small cell lung cancer.
Adeyemo OM; Ashimiyu-Abdusalam Z; Adewunmi M; Ayano TA; Sohaib M; Abdel-Salam R
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2031. PubMed ID: 38600056
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis.
MotieGhader H; Safavi E; Rezapour A; Amoodizaj FF; Iranifam RA
Sci Rep; 2021 Nov; 11(1):21872. PubMed ID: 34750486
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA).
Kui L; Li M; Yang X; Yang L; Kong Q; Pan Y; Xu Z; Wang S; Mo D; Dong Y; Liu Y; Miao J
Biomed Res Int; 2021; 2021():5955343. PubMed ID: 34485520
[TBL] [Abstract][Full Text] [Related]
5. Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks.
Qin S; Li W; Yu H; Xu M; Li C; Fu L; Sun S; He Y; Lv J; He W; Chen L
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768566
[TBL] [Abstract][Full Text] [Related]
6. Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma.
Graves OK; Kim W; Özcan M; Ashraf S; Turkez H; Yuan M; Zhang C; Mardinoglu A; Li X
Biomed Pharmacother; 2023 May; 161():114486. PubMed ID: 36906970
[TBL] [Abstract][Full Text] [Related]
7. Identification of the shared gene signatures and molecular mechanisms between multiple sclerosis and non-small cell lung cancer.
Yang J; Hu X; Wang Y; Liu W; Zhang M; Zhang A; Ni B
Front Immunol; 2023; 14():1180449. PubMed ID: 37251402
[TBL] [Abstract][Full Text] [Related]
8. Network-based drug repurposing for schizophrenia.
Truong TTT; Liu ZSJ; Panizzutti B; Kim JH; Dean OM; Berk M; Walder K
Neuropsychopharmacology; 2024 May; 49(6):983-992. PubMed ID: 38321095
[TBL] [Abstract][Full Text] [Related]
9. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems.
Doumat G; Daher D; Zerdan MB; Nasra N; Bahmad HF; Recine M; Poppiti R
Curr Oncol; 2023 Jan; 30(1):704-719. PubMed ID: 36661704
[TBL] [Abstract][Full Text] [Related]
11. DM-MOGA: a multi-objective optimization genetic algorithm for identifying disease modules of non-small cell lung cancer.
Shang J; Zhu X; Sun Y; Li F; Kong X; Liu JX
BMC Bioinformatics; 2023 Jan; 24(1):13. PubMed ID: 36624376
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of GWAS and transcriptomics data reveal key genes for non-small lung cancer.
Feng X
Med Oncol; 2023 Aug; 40(9):270. PubMed ID: 37592093
[TBL] [Abstract][Full Text] [Related]
13. Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing.
Rajasegaran T; How CW; Saud A; Ali A; Lim JCW
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986550
[TBL] [Abstract][Full Text] [Related]
14. Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma.
Yesharim L; Teimourian S
Cancer Biol Ther; 2023 Dec; 24(1):2253586. PubMed ID: 37710391
[TBL] [Abstract][Full Text] [Related]
15. Inference of differential key regulatory networks and mechanistic drug repurposing candidates from scRNA-seq data with SCANet.
Oubounyt M; Adlung L; Patroni F; Wenke NK; Maier A; Hartung M; Baumbach J; Elkjaer ML
Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37862243
[TBL] [Abstract][Full Text] [Related]
16. Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing.
Liu C; Leighow SM; McIlroy K; Lu M; Dennis KA; Abello K; Brown DJ; Moore CJ; Shah A; Inam H; Rivera VM; Pritchard JR
Cell Rep Med; 2023 Oct; 4(10):101227. PubMed ID: 37852183
[TBL] [Abstract][Full Text] [Related]
17. Exploring Drug Treatment Patterns Based on the Action of Drug and Multilayer Network Model.
Yu L; Shi Y; Zou Q; Wang S; Zheng L; Gao L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708644
[TBL] [Abstract][Full Text] [Related]
18. Network neighborhood operates as a drug repositioning method for cancer treatment.
Cüvitoğlu A; Isik Z
PeerJ; 2023; 11():e15624. PubMed ID: 37456868
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide positioning systems network algorithm for in silico drug repurposing.
Cheng F; Lu W; Liu C; Fang J; Hou Y; Handy DE; Wang R; Zhao Y; Yang Y; Huang J; Hill DE; Vidal M; Eng C; Loscalzo J
Nat Commun; 2019 Aug; 10(1):3476. PubMed ID: 31375661
[TBL] [Abstract][Full Text] [Related]
20. NMSDR: Drug repurposing approach based on transcriptome data and network module similarity.
Ünsal Ü; Cüvitoğlu A; Turhan K; Işık Z
Mol Inform; 2023 Mar; 42(3):e2200077. PubMed ID: 36411244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
